Publications in collaboration with researchers from Universidad Católica San Antonio (1)

2020

  1. Effectiveness of fingolimod versus natalizumab as second-line therapy for relapsing-remitting multiple sclerosis in Spain: Second-Line GATE study

    European Neurology, Vol. 83, Núm. 1, pp. 25-33